mitomycin has been researched along with Pancreatic Fistula in 1 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
Pancreatic Fistula: Abnormal passage communicating with the PANCREAS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Performing splenectomy and CDDP dosage for HIPEC >240 mg were proven to be independent risk factors for both G3-4 hyperamylasemia and POPF." | 1.34 | Incidence of postoperative pancreatic fistula and hyperamylasemia after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. ( Antonucci, A; Baratti, D; Deraco, M; Gavazzi, C; Kusamura, S; Laterza, B; Oliva, GD; Younan, R, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kusamura, S | 1 |
| Baratti, D | 1 |
| Antonucci, A | 1 |
| Younan, R | 1 |
| Laterza, B | 1 |
| Oliva, GD | 1 |
| Gavazzi, C | 1 |
| Deraco, M | 1 |
1 other study available for mitomycin and Pancreatic Fistula
| Article | Year |
|---|---|
Incidence of postoperative pancreatic fistula and hyperamylasemia after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; D | 2007 |